LOPID Drug Patent Profile

✉ Email this page to a colleague

When do Lopid patents expire, and what generic alternatives are available?

Lopid is a drug marketed by Pfizer Pharms and is included in one NDA.

The generic ingredient in LOPID is gemfibrozil. Thirty-four suppliers are listed for this compound. Additional details are available on the gemfibrozil profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Lopid

A generic version of LOPID was approved as gemfibrozil by CHARTWELL MOLECULES on September 27^th, 1993.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for LOPID?
What are the global sales for LOPID?
What is Average Wholesale Price for LOPID?

Summary for LOPID

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	134
Patent Applications:	4,053
Drug Prices:	Drug price information for LOPID
What excipients (inactive ingredients) are in LOPID?	LOPID excipients list
DailyMed Link:	LOPID at DailyMed

Drug patent expirations by year for LOPID

Pharmacology for LOPID

Drug Class	Peroxisome Proliferator Receptor alpha Agonist
Mechanism of Action	Peroxisome Proliferator-activated Receptor alpha Agonists

US Patents and Regulatory Information for LOPID

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pfizer Pharms	LOPID	gemfibrozil	CAPSULE;ORAL	018422-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Pfizer Pharms	LOPID	gemfibrozil	CAPSULE;ORAL	018422-002	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Pfizer Pharms	LOPID	gemfibrozil	TABLET;ORAL	018422-003	Nov 20, 1986	AB	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for LOPID

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pfizer Pharms	LOPID	gemfibrozil	CAPSULE;ORAL	018422-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Pfizer Pharms	LOPID	gemfibrozil	CAPSULE;ORAL	018422-002	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for LOPID

See the table below for patents covering LOPID around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
South Africa	6905769		⤷ Sign Up
Brazil	6911856		⤷ Sign Up
Netherlands	148872		⤷ Sign Up
Netherlands	6912790		⤷ Sign Up
Germany	1925423		⤷ Sign Up
Austria	291228		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for LOPID

Pharmacology for LOPID

Make Better Decisions: Try a trial or see plans & pricing